Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Šiftar, Z."'
Publikováno v:
In Leukemia Research Reports 2024 21 Supplement
Autor:
Mandac Rogulj, I., Kardum Paro, M.M., Martinović, M., Kaić, G., Šiftar, Z., Ostojić Kolonić, S.
Publikováno v:
In Clinica Chimica Acta 1 May 2022 530 Supplement 1:S337-S337
Publikováno v:
In Clinica Chimica Acta June 2019 493 Supplement 1:S702-S702
Autor:
Paro, M.M. Kardum, Taradi, I., Krišto, D. Radić, Rogulj, I. Mandac, Kolonić, S. Ostojić, Kursar, M., Šiftar, Z.
Publikováno v:
In Clinica Chimica Acta June 2019 493 Supplement 1:S419-S419
Background. Implementation of new analytical equipment into routine work requires verification procedure. We have verified flow cytometer Becton Dickinson FACSCanto II for ISHAGE protocol (Sutherland et al, 1996, J Hematotherapy, 5:213-226) stem cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::ac76e028c60d3475ecb0cc7429aaa6eb
https://www.bib.irb.hr/599016
https://www.bib.irb.hr/599016
Aim: Molecular analysis of T cell receptor (TCR) and immunoglobulin (Ig) genes rearrangement is often a useful adjunct to the patohistological diagnosis (PHD) in discrimination between reactive and malignant proliferations, specially in cases of clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::72bbaee2e62670fe651c2fef37bf61c2
https://www.bib.irb.hr/597915
https://www.bib.irb.hr/597915
Background. Croatian EQA involves participation in the National External Quality Assurance Scheme organized under the auspices of the Croatian Society of Medical Biochemists by processing of unknown samples 3 times per annum. The suitability of home-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::ddbca2f40b9110d36eeb57f78a643307
https://www.bib.irb.hr/599005
https://www.bib.irb.hr/599005
Autor:
Fabijanić, I, Kardum-Skelin, Ika, Šušterčić, Dunja, Cvrlje-Čolić, Vesna, Naumovski-Mihalić, Slavica, Škegro, Dinko, Šiftar, Z, Kušec, Rajo, Anić, P., Jakšić, Branimir
Introduction: Posttransplant lymphoproliferative disorders (PTLD) represent an immunophenotypic, genotypic, and clinical spectrum of diseases seen in patients after bone marrow and solid-organ transplantation (SOT). PTLD are mostly of B-cell origin a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::3574c77170b5938e4102aeba749f2076
https://www.bib.irb.hr/227361
https://www.bib.irb.hr/227361
Autor:
Fabijanić, Iris, Kardum-Skelin, Ika, Šušterčić, Dunja, Cvrlje-Čolić, V., Naumovski-Mihalić, S., Škegro D., Šiftar Z, Kušec R, Anić P, Jakšić, Branimir
Introduction: Posttransplant lymphoproliferative disorders (PTLD) represent an immunophenotypic, genotypic, and clinical spectrum of diseases seen in patients after bone marrow and solid-organ transplantation (SOT). PTLD are mostly of B-cell origin a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::b10639b589f4bc19a0887ad3f82029f1
https://www.bib.irb.hr/218657
https://www.bib.irb.hr/218657
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.